An interventional study of Tegaderm Eye Tape and Transpore Eye Tape in Eyelid Erythema, sponsored by Tufts Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-28.
Sponsored by Tufts Medical Center · Not applicable, Interventional, and Other
The purpose of this study is to compare the rate of eyelid erythema after anesthesia with the use of TegadermTM vs. the Transpore®. Our null hypothesis is that the rate of erythema will be similar between the two groups given there is no evidence currently to suggest otherwise
At Tufts Medical Center, a variety of adhesive tapes are used to shut the eyes during anesthesia, including 3MTM TegadermTM and the Sharn Anesthesia Transpore®, with no preference for one or the other. While all of these products decrease the risk of corneal abrasion, none of these products have been shown to be superior to the others in terms of eyelid irritation. According to Sharn Anesthesia, "The [Transpore®] adhesive is light enough to reduce damage to the outer eye" (3). However, there is no scientific evidence to support this claim. All the investigators know is that the Transpore is coated with a medical grade, pressure-sensitive acrylic adhesive and that there are no phthalates, it is latex free and silicone free.
131 studies on the registry are indexed under Erythema; 17 are open to participants now.
This study's enrollment of 165 is above the median of 50 across 114 interventional studies indexed under Erythema.
Browse Erythema studies →Tufts Medical Center is the lead sponsor of 200 studies on the registry; 28 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 16 (50%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
After general anesthesia is administered, Tegaderm will be placed on the left eye and Transpore will be placed on the right eye
Device: Tegaderm Eye Tape
After general anesthesia is administered, Transpore will be placed on the right eye and Tegaderm will be placed on the left eye.
Device: Transpore Eye Tape
Eye tape to protect the eye from corneal abrasions during surgery.
Eye tape to protect the eye from corneal abrasions during surgery.
The proportion of eyelids with erythema at the end of surgery after removal of Tegaderm vs. Transpore
Degree of erythema seen in the photo taken of the eyelid immediately after the tape is removed after surgery
Time frame: Immediately after tape removal
Epidermal Change
Any epidermal changes seen on the eyelid
Time frame: Immediately after tape removal
Edema
Edema seen after eye tape removal
Time frame: Immediately after tape removal
Plan to share: No — There are no plans to share the individual participant data. The individual patient records will be kept secure in an office setting.
This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.